WHERE HEALTHCARE AND SCIENCE CONVERGE
DEAD

Serial Number

85175434

Owner

Saint Joseph's University

Attorney

Christopher D. Olszyk, Jr.

First Use Date

Sep 1, 2010

Filing Date

Nov 12, 2010

Add to watchlist:

No watchlists yet
View on USPTO

WHERE HEALTHCARE AND SCIENCE CONVERGE Trademark

Serial Number: 85175434 • Registration: 4199188

WHERE HEALTHCARE AND SCIENCE CONVERGE is a trademark filed by Saint Joseph's University on November 12, 2010. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Saint Joseph's University (32 trademarks)

Philadelphia, PA 19131

Entity Type: 03

University of the Sciences in Philadelphia (17 trademarks)

600 South 43rd Street
Philadelphia, PA 19104

Entity Type: 99

Trademark Details

Filing Date

November 12, 2010

Registration Date

August 28, 2012

First Use Anywhere

September 1, 2010

First Use in Commerce

September 1, 2010

Published for Opposition

October 4, 2011

Cancellation Date

March 10, 2023

Goods & Services

Educational services, namely, providing courses of instruction at the undergraduate, graduate, and post-graduate levels; educational services, namely, providing educational undergraduate, graduate, and post-graduate level research programs for all aspects of pharmaceutical study; providing continuing education conferences, seminars and workshops in the fields of pharmaceutical study, health care, and health sciences; conducting educational conferences and seminars in the fields of the study of pharmacy and the pharmaceutical and health care industries; publication of newsletters, news briefs, and monographs for pharmacists and health care professionals; entertainment services in the nature of presentation of a variety of intercollegiate sporting events, namely, cross-country running, [ cheerleading, rifle, ] basketball, baseball, golf, tennis, softball, and volleyball

[ Providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, research about patient reimbursement for pharmaceuticals and financing the research of others in the field of pharmacoeconomics; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, financing the research of others ]

[ Business consulting services for the pharmaceutical and health care industries, namely, pharmaceutical care management programs in the nature of cost management and drug utilization review for pharmaceutical benefit plans for private and public agencies, organizations, institutions, and individuals; Business research services, namely, providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy utilization and costs reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly, namely, drug utilization review research for the pharmaceutical and health care industries ]

[ Technical consulting services in the nature of pharmaceutical technology consulting for pharmaceutical care management programs provided to private and public agencies, organizations, institutions, and individuals for the pharmaceutical and health care industries; Research consulting services in the nature of pharmaceutical research services for pharmaceutical care management programs for private and public agencies, organizations, institutions, and individuals in the pharmaceutical and health care industries; providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy selection, utilization, costs, and reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, pharmaceutical research services; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, research in the field of pharmaceuticals ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Mar 10, 2023 CAEX
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2022 ASGN
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 28, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 14, 2018 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 14, 2018 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 24, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 16, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 28, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 21, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jul 20, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 16, 2012 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 25, 2012 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 25, 2012 AITU
USE AMENDMENT FILED
May 29, 2012 IUAF
TEAS STATEMENT OF USE RECEIVED
May 29, 2012 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 1, 2011 PREV
ASSIGNED TO LIE
Aug 31, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2011 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 26, 2011 GPRN
PRIORITY ACTION E-MAILED
Feb 26, 2011 GPRA
PRIORITY ACTION WRITTEN
Feb 26, 2011 CPRA
ASSIGNED TO EXAMINER
Feb 23, 2011 DOCK
NOTICE OF PSEUDO MARK MAILED
Nov 18, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2010 NWOS
NEW APPLICATION ENTERED
Nov 16, 2010 NWAP